Meridian Bioscience (VIVO) Reports In-Line Q3 EPS of $0.19; Guides
Tweet Send to a Friend
Meridian Bioscience, Inc. (NASDAQ: VIVO) reports Q3 non-GAAP EPS of $0.19, in-line with the analyst estimate of $0.19. Revenues ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
